Clinical trials investigating the diagnostic and prognostic value of GDF-15 and Klotho in DCM and exploring the therapeutic potential of targeting senescence and macrophages, including the modulation of GDF-15 and Klotho, are warranted to translate the research findings into clinical practice. The gene discussed is GDF15; the disease is familial dilated cardiomyopathy.